Ulaner, G. A., Saura, C., Piha-Paul, S. A., Mayer, I., Quinn, D., Jhaveri, K., . . . Hyman, D. M. (2019). Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib. Clin Cancer Res.
Trích dẫn kiểu ChicagoUlaner, Gary A., et al. "Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib." Clin Cancer Res 2019.
Trích dẫn MLAUlaner, Gary A., et al. "Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib." Clin Cancer Res 2019.